| pubmed-article:21362743 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21362743 | lifeskim:mentions | umls-concept:C0162429 | lld:lifeskim |
| pubmed-article:21362743 | lifeskim:mentions | umls-concept:C0018220 | lld:lifeskim |
| pubmed-article:21362743 | lifeskim:mentions | umls-concept:C0152309 | lld:lifeskim |
| pubmed-article:21362743 | lifeskim:mentions | umls-concept:C0036341 | lld:lifeskim |
| pubmed-article:21362743 | lifeskim:mentions | umls-concept:C0012236 | lld:lifeskim |
| pubmed-article:21362743 | lifeskim:mentions | umls-concept:C0220704 | lld:lifeskim |
| pubmed-article:21362743 | lifeskim:mentions | umls-concept:C0011155 | lld:lifeskim |
| pubmed-article:21362743 | lifeskim:mentions | umls-concept:C0004083 | lld:lifeskim |
| pubmed-article:21362743 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:21362743 | pubmed:dateCreated | 2011-5-3 | lld:pubmed |
| pubmed-article:21362743 | pubmed:abstractText | Individuals with 22q11.2 deletion syndrome are known to be at high risk of developing schizophrenia. Previous imaging studies have provided limited data on the relation of schizophrenia expression in 22q11.2 deletion syndrome to specific regional brain volumetric changes. The authors hypothesized that the main structural brain finding associated with schizophrenia expression in 22q11.2 deletion syndrome, as for schizophrenia in the general population, would be gray matter volumetric deficits, especially in the temporal lobes. | lld:pubmed |
| pubmed-article:21362743 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21362743 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21362743 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21362743 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21362743 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21362743 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21362743 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21362743 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:21362743 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21362743 | pubmed:month | May | lld:pubmed |
| pubmed-article:21362743 | pubmed:issn | 1535-7228 | lld:pubmed |
| pubmed-article:21362743 | pubmed:author | pubmed-author:CrawleyAdrian... | lld:pubmed |
| pubmed-article:21362743 | pubmed:author | pubmed-author:ChowEva W CEW | lld:pubmed |
| pubmed-article:21362743 | pubmed:author | pubmed-author:BassettAnne... | lld:pubmed |
| pubmed-article:21362743 | pubmed:author | pubmed-author:HoAndrewA | lld:pubmed |
| pubmed-article:21362743 | pubmed:author | pubmed-author:WeiCorieC | lld:pubmed |
| pubmed-article:21362743 | pubmed:author | pubmed-author:VoormolenEdua... | lld:pubmed |
| pubmed-article:21362743 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21362743 | pubmed:volume | 168 | lld:pubmed |
| pubmed-article:21362743 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21362743 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21362743 | pubmed:pagination | 522-9 | lld:pubmed |
| pubmed-article:21362743 | pubmed:meshHeading | pubmed-meshheading:21362743... | lld:pubmed |
| pubmed-article:21362743 | pubmed:meshHeading | pubmed-meshheading:21362743... | lld:pubmed |
| pubmed-article:21362743 | pubmed:meshHeading | pubmed-meshheading:21362743... | lld:pubmed |
| pubmed-article:21362743 | pubmed:meshHeading | pubmed-meshheading:21362743... | lld:pubmed |
| pubmed-article:21362743 | pubmed:meshHeading | pubmed-meshheading:21362743... | lld:pubmed |
| pubmed-article:21362743 | pubmed:meshHeading | pubmed-meshheading:21362743... | lld:pubmed |
| pubmed-article:21362743 | pubmed:meshHeading | pubmed-meshheading:21362743... | lld:pubmed |
| pubmed-article:21362743 | pubmed:meshHeading | pubmed-meshheading:21362743... | lld:pubmed |
| pubmed-article:21362743 | pubmed:meshHeading | pubmed-meshheading:21362743... | lld:pubmed |
| pubmed-article:21362743 | pubmed:meshHeading | pubmed-meshheading:21362743... | lld:pubmed |
| pubmed-article:21362743 | pubmed:meshHeading | pubmed-meshheading:21362743... | lld:pubmed |
| pubmed-article:21362743 | pubmed:meshHeading | pubmed-meshheading:21362743... | lld:pubmed |
| pubmed-article:21362743 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21362743 | pubmed:articleTitle | Association of schizophrenia in 22q11.2 deletion syndrome and gray matter volumetric deficits in the superior temporal gyrus. | lld:pubmed |
| pubmed-article:21362743 | pubmed:affiliation | Clinical Genetics Research Program, Centre for Addiction and Mental Health, Toronto, Canada. eva.chow@utoronto.ca | lld:pubmed |
| pubmed-article:21362743 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21362743 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
